Entelos Signs Metabolism PhysioLab Deal with Roche
Roche and Entelos have entered into a two-year collaboration in which Entelos will conduct biosimulation research using its Metabolism PhysioLab platform, the companies said this week.
Roche will provide R&D funding and milestone payments to Entelos.
Additional financial terms were not disclosed.
Roche will use the data from the collaboration to analyze "existing preclinical and clinical data in order to optimize future clinical trials," the companies said in a statement.